This article is more than 5 years old. Information may no longer be current.

Crystalens 3-year data shows high level of vision maintained

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ALISO VIEJO, Calif. – After 3 years, 92% of patients implanted with an accommodating IOL still report monocular near visual acuity of J3 or better, according to the lens maker.

At 1 year follow-up, 92% of 241 patients implanted with the eyeonics Crystalens achieved J3 or better near vision, Now in 192 patients that have reached the 3-year mark, that percentage remains the same, company officials told Ocular Surgery News.

Further, at 1 year, 90% of 124 patients achieved 20/25 or better bilateral uncorrected distance vision, and at 3 years, 90% of 50 patients have maintained that level of vision, according to eyeonics officials.

No patients showed a loss of accommodation, with uncorrected intermediate vision of J3 or better at 3-year follow-up.

The Crystalens, designed to provide a continuous range of vision from distance through intermediate to near, is approved in the United States for patients undergoing cataract surgery and presbyopia correction, a company press release noted.